Once upon a time (3-4 yrs ago) it was a great stock. Now beaten down just like many other pharma stocks. However of late there is some perceptible recovery in select pharma stocks. Lupin created a small base and trying to limp up. After more than one year price today has reached 200 DMA and this is worth noting since it changes the trend.